Showing results (21-30 of 70) with videos related to
Sort By:
Pageof 7
Health Affairs (Project Hope)|February 4, 2015
Repairing the broken market for antibiotic innovationKevin Outterson, John H Powers, Gregory W Daniel, et al.Clinical Pharmacology and Therapeutics|April 23, 2021
Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product EffectivenessNirosha Mahendraratnam, Kerra Mercon, Mira Gill, et al.North Carolina Medical Journal|November 3, 2020
The Past Decade of Paying for Value : From the Affordable Care Act to COVID-19Hannah Crook, Rebecca Whitaker, William Bleser, et al.Health Services Research|March 23, 2004
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of lifeAmber E Barnato, Mark B McClellan, Christopher R Kagay, et al.Plos One|April 18, 2023
The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorderEthan D Borre, Evan Myers, Marianne Hamilton Lopez, et al.Journal of Oncology Practice|February 13, 2018
Meaningful Physician Payment Reform in OncologyKavita K Patel, Alexander J Morin, Jeffrey L Nadel, et al.Journal of General Internal Medicine|November 10, 2020
Correction to: Comparing Associations of State Reopening Strategies with COVID-19 BurdenBrystana G Kaufman, Rebecca Whitaker, Nirosha Mahendraratnam, et al.Journal of General Internal Medicine|October 6, 2020
Comparing Associations of State Reopening Strategies with COVID-19 BurdenBrystana G Kaufman, Rebecca Whitaker, Nirosha Mahendraratnam, et al.American Heart Journal|September 14, 2002
Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995Mark A Hlatky, Olga Saynina, Kathryn M McDonald, et al.The American Journal of Medicine|May 17, 2002
Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiariesJ Peter Weiss, Olga Saynina, Kathryn M McDonald, et al.Pageof 7